Rivaroxaban Versus Warfarin for Prevention of Thromboembolism in Bangladeshi Patients With Non-Valvular Atrial Fibrillation. Univ. Heart J. 2020, 16 (2), 99-105. https://doi.org/10.3329/uhj.v16i2.49666.